Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies.
Several monoclonal antibodies directed against gonococcal pili have been used to investigate the potential contribution of anti-pilus antibodies to host defense against gonococcal infection. Included were two antibodies (SM1 and SM2) which reacted with conserved determinants present on pili from all strains tested and others which exhibited antigenic specificity. Immunoblotting experiments revealed that antibodies SM1 and SM2 recognize epitopes on two different peptides derived by CNBr cleavage of alpha-pili from Neisseria gonorrhoeae P9-2. All antibodies used were capable of activating complement, as shown by their ability to bind Clq, and one type-specific antibody was effective in complement-mediated bactericidal killing. Antibodies directed against at least some pilus epitopes may therefore contribute to bactericidal activity during the course of natural infection. The opsonic effect of type-specific antibodies was demonstrated by their ability to stimulate luminol-dependent chemiluminescence of human polymorphonuclear leukocytes and promote phagocytic killing of variant P9-2. Phagocytic killing in the presence of each monoclonal antibody paralleled the increase in chemiluminescence, suggesting that for this variant killing was an inevitable consequence of the interaction of polymorphonuclear leukocytes with gonococci opsonized with anti-pilus antibodies. Antibody-mediated chemiluminescence of polymorphonuclear leukocytes was enhanced in the presence of human complement, and a weak opsonic effect was detected with one of the cross-reacting antibodies (SM1) when this system was used. Although cross-reacting antibody SM1 and type-specific antibody SM13 showed considerable differences in biological properties, they were of the same isotype and bound to native pili on intact gonococci in similar numbers and with similar avidity.
M
M
Virji
J E
JE
Heckels
D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001770:Blood Bactericidal Activity; D003165:Complement System Proteins / Q000276:immunology; D000939:Epitopes / Q000032:analysis; D010861:Fimbriae, Bacterial / Q000276:immunology*; D006069:Gonorrhea / Q000276:immunology*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D010587:Phagocytosis
D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D000939:Epitopes; D003165:Complement System Proteins